• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国涉及器官移植的同行评审出版物中报告供体来源和伦理审查的道德标准遵循情况:范围综述。

Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.

机构信息

Department of Clinical Medicine and Department of Philosophy, Macquarie University, Sydney, New South Wales, Australia.

Department of Philosophy, Macquarie University, Sydney, New South Wales, Australia.

出版信息

BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473.

DOI:10.1136/bmjopen-2018-024473
PMID:30723071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6377532/
Abstract

OBJECTIVES

The objective of this study is to investigate whether papers reporting research on Chinese transplant recipients comply with international professional standards aimed at excluding publication of research that: (1) involves any biological material from executed prisoners; (2) lacks Institutional Review Board (IRB) approval and (3) lacks consent of donors.

DESIGN

Scoping review based on Arksey and O'Mallee's methodological framework.

DATA SOURCES

Medline, Scopus and Embase were searched from January 2000 to April 2017.

ELIGIBILITY CRITERIA

We included research papers published in peer-reviewed English-language journals reporting on outcomes of research involving recipients of transplanted hearts, livers or lungs in mainland China.

DATA EXTRACTION AND SYNTHESIS

Data were extracted by individual authors working independently following training and benchmarking. Descriptive statistics were compiled using Excel.

RESULTS

445 included studies reported on outcomes of 85 477 transplants. 412 (92.5%) failed to report whether or not organs were sourced from executed prisoners; and 439 (99%) failed to report that organ sources gave consent for transplantation. In contrast, 324 (73%) reported approval from an IRB. Of the papers claiming that no prisoners' organs were involved in the transplants, 19 of them involved 2688 transplants that took place prior to 2010, when there was no volunteer donor programme in China.

DISCUSSION

The transplant research community has failed to implement ethical standards banning publication of research using material from executed prisoners. As a result, a large body of unethical research now exists, raising issues of complicity and moral hazard to the extent that the transplant community uses and benefits from the results of this research. We call for retraction of this literature pending investigation of individual papers.

摘要

目的

本研究旨在调查报告中国器官移植受者研究的论文是否符合旨在排除发表涉及以下内容的研究的国际专业标准:(1) 使用来自已处决囚犯的任何生物材料;(2) 缺乏机构审查委员会(IRB) 批准;(3) 缺乏供体同意。

设计

基于 Arksey 和 O'Mallee 方法学框架的范围审查。

数据来源

从 2000 年 1 月至 2017 年 4 月,检索 Medline、Scopus 和 Embase。

入选标准

纳入发表在同行评议的英文期刊上的研究论文,报告中国大陆接受心脏、肝脏或肺移植的受者的研究结果。

数据提取和综合

作者经过培训和基准测试后,独立提取数据。使用 Excel 汇总描述性统计数据。

结果

445 项纳入研究报告了 85477 例移植的结果。412 项(92.5%)未报告器官是否来源于已处决的囚犯;439 项(99%)未报告器官来源是否同意进行移植。相比之下,324 项(73%)报告了 IRB 的批准。在声称没有涉及囚犯器官的论文中,有 19 项涉及 2010 年之前进行的 2688 例移植,当时中国没有志愿供体计划。

讨论

移植研究界未能实施禁止使用来自已处决囚犯的材料进行研究的伦理标准。结果,大量不道德的研究现在已经存在,引起了同谋和道德风险的问题,以至于移植界使用和受益于这项研究的结果。我们呼吁撤回这些文献,同时等待对个别论文进行调查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/ddd2a23fa94c/bmjopen-2018-024473f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/31a01249f414/bmjopen-2018-024473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/320ed60bbd2f/bmjopen-2018-024473f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/ddd2a23fa94c/bmjopen-2018-024473f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/31a01249f414/bmjopen-2018-024473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/320ed60bbd2f/bmjopen-2018-024473f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f90/6377532/ddd2a23fa94c/bmjopen-2018-024473f03.jpg

相似文献

1
Compliance with ethical standards in the reporting of donor sources and ethics review in peer-reviewed publications involving organ transplantation in China: a scoping review.中国涉及器官移植的同行评审出版物中报告供体来源和伦理审查的道德标准遵循情况:范围综述。
BMJ Open. 2019 Feb 5;9(2):e024473. doi: 10.1136/bmjopen-2018-024473.
2
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
3
Transplant Medicine in China: Need for Transparency and International Scrutiny Remains.中国的移植医学:仍需透明度和国际监督。
Am J Transplant. 2016 Nov;16(11):3115-3120. doi: 10.1111/ajt.14014. Epub 2016 Sep 19.
4
The use of executed prisoners as a source of organ transplants in China must stop.中国必须停止使用已处决囚犯作为器官移植的来源。
Am J Transplant. 2011 Mar;11(3):426-8. doi: 10.1111/j.1600-6143.2010.03417.x.
5
Smoke and mirrors: unanswered questions and misleading statements obscure the truth about organ sources in China.烟雾与镜子:未解答的问题和误导性陈述掩盖了中国器官来源的真相。
J Med Ethics. 2016 Aug;42(8):552-3. doi: 10.1136/medethics-2016-103533. Epub 2016 May 4.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Human rights violations in organ procurement practice in China.中国器官获取行为中的侵犯人权现象。
BMC Med Ethics. 2017 Feb 8;18(1):11. doi: 10.1186/s12910-017-0169-x.
8
Institutional review board approval and publication of human research results.机构审查委员会对人体研究结果的批准与发表。
JAMA. 1997 Mar 19;277(11):909-14.
9
Ethics of organ donation and transplantation involving prisoners: the debate extends beyond our borders.涉及囚犯的器官捐赠与移植伦理:这场辩论已超越我们的国界。
Intern Med J. 2008 Jan;38(1):56-9. doi: 10.1111/j.1445-5994.2007.01563.x.
10
What is the quality of the reporting of research ethics in publications of nursing home research?疗养院研究出版物中研究伦理报告的质量如何?
J Am Geriatr Soc. 1999 Jan;47(1):76-81. doi: 10.1111/j.1532-5415.1999.tb01904.x.

引用本文的文献

1
Editorial - The Secret Life of Retractions in Scientific Publications.社论——科学出版物撤稿的隐秘情况
Princ Pract Clin Res. 2023 Jul 10;9(1). doi: 10.21801/ppcrj.2023.91.2. Epub 2023 Jul 24.
2
Trinity review: integrating Registered Reports with research ethics and funding reviews.三位一体评审:将注册报告与研究伦理和资金评审相结合。
BMC Res Notes. 2022 May 19;15(1):184. doi: 10.1186/s13104-022-06043-x.
3
Retraction Note: In-hospital cerebrovascular complications following orthotopic liver transplantation: A retrospective study.

本文引用的文献

1
Papers based on data concerning organs from executed prisoners should not be published: Response to Zheng and Yan.基于来自死刑犯器官数据的论文不应发表:对郑(某)和严(某)的回应。
Liver Int. 2017 May;37(5):771-772. doi: 10.1111/liv.13366.
2
Fatigue and its associated factors in liver transplant recipients in Beijing: a cross-sectional study.北京肝移植受者的疲劳及其相关因素:一项横断面研究。
BMJ Open. 2017 Feb 23;7(2):e011840. doi: 10.1136/bmjopen-2016-011840.
3
Human rights violations in organ procurement practice in China.中国器官获取行为中的侵犯人权现象。
撤稿说明:原位肝移植术后院内脑血管并发症:一项回顾性研究。
BMC Neurol. 2021 Apr 10;21(1):155. doi: 10.1186/s12883-021-02175-y.
4
Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation.撤回声明:循环中的FoxP3 +调节性T细胞和产生白细胞介素17的Th17细胞对原位肝移植后初发乙型肝炎病毒感染患者的HBV清除有积极影响。
PLoS One. 2019 Dec 2;14(12):e0226148. doi: 10.1371/journal.pone.0226148. eCollection 2019.
5
Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.撤稿声明:白细胞介素-22在肝移植后复发性丙型肝炎发生发展中的病理作用
PLoS One. 2019 Nov 26;14(11):e0225971. doi: 10.1371/journal.pone.0225971. eCollection 2019.
6
Ethics of publication, between forgery, retraction and protecting freedom: an ENJOY score for authors and editors.出版伦理,介于伪造、撤稿与保护自由之间:作者和编辑的ENJOY评分
J Nephrol. 2019 Dec;32(6):847-850. doi: 10.1007/s40620-019-00645-8. Epub 2019 Sep 17.
7
Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.撤回声明:肝细胞癌肝移植患者三种不同免疫抑制方案的综合比较:无类固醇免疫抑制、诱导免疫抑制和标准免疫抑制。
PLoS One. 2019 Sep 10;14(9):e0222507. doi: 10.1371/journal.pone.0222507. eCollection 2019.
8
A 10-year follow up of publishing ethics in China: what is new and what is unchanged.中国出版伦理十年随访:有何新变化,有何未改变之处。
Res Integr Peer Rev. 2019 Sep 2;4:17. doi: 10.1186/s41073-019-0077-3. eCollection 2019.
9
Retraction: Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study.撤稿声明:术中冷沉淀输血及其与肝移植术后胆道并发症发生率的关联——一项回顾性队列研究
PLoS One. 2019 Sep 6;14(9):e0222377. doi: 10.1371/journal.pone.0222377. eCollection 2019.
10
Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.撤回:肝移植术后缺血型胆管病变的新诊断与治疗模式——一项回顾性队列研究
PLoS One. 2019 Sep 6;14(9):e0222409. doi: 10.1371/journal.pone.0222409. eCollection 2019.
BMC Med Ethics. 2017 Feb 8;18(1):11. doi: 10.1186/s12910-017-0169-x.
4
Papers based on data concerning organs from executed prisoners should not be published.基于来自死刑犯器官数据的论文不应发表。
Liver Int. 2017 May;37(5):769. doi: 10.1111/liv.13348. Epub 2017 Jan 30.
5
The predictive value of blood neutrophil-lymphocyte ratio in patients with end-stage liver cirrhosis following ABO-incompatible liver transplantation.ABO血型不相容肝移植术后终末期肝硬化患者血液中性粒细胞与淋巴细胞比值的预测价值
J Res Med Sci. 2016 Sep 1;21:69. doi: 10.4103/1735-1995.189653. eCollection 2016.
6
Organ Donation and Transplantation From Donors With Systemic Infection: A Single-Center Experience.来自患有全身性感染供体的器官捐献与移植:单中心经验
Transplant Proc. 2016 Sep;48(7):2454-2457. doi: 10.1016/j.transproceed.2016.02.092.
7
Retraction: "Safety limitations of fatty liver transplantation can be extended to 40%: Experience of a single centre in China", by Yu Z., Yu S., Zhang L., Feng X., Zhang M., et al.撤稿声明:《脂肪肝移植的安全限度可扩展至40%:中国单中心经验》,作者为余Z、余S、张L、冯X、张M等。
Liver Int. 2017 May;37(5):767. doi: 10.1111/liv.13244. Epub 2016 Oct 13.
8
Health-Related Quality of Life and Psychological Distress in Patients With Early-Stage Hepatocellular Carcinoma After Hepatic Resection or Transplantation.肝切除或移植术后早期肝细胞癌患者的健康相关生活质量和心理困扰
Transplant Proc. 2016 Jul-Aug;48(6):2107-11. doi: 10.1016/j.transproceed.2016.04.012.
9
Liver Transplantation Using Donation After Brain and Cardiac Death: A Single-Center Experience in China.脑心死亡后器官捐献肝脏移植:中国单中心经验
Transplant Proc. 2016 Jul-Aug;48(6):1879-86. doi: 10.1016/j.transproceed.2016.03.054.
10
The organ preservation and enhancement of donation success ratio effect of extracorporeal membrane oxygenation in circulatory unstable brain death donor.体外膜肺氧合对循环不稳定脑死亡供者器官保存及提高供者成功率的作用
Clin Transplant. 2016 Oct;30(10):1306-1313. doi: 10.1111/ctr.12823. Epub 2016 Sep 5.